Single-Pattern Convergence of K-ras Mutation Correlates With Surgical Indication of Intraductal Papillary Mucinous Neoplasms

被引:9
作者
Mizuno, Osamu [1 ]
Kawamoto, Hirofumi [1 ]
Yamamoto, Naoki [1 ]
Horiguchi, Shigeru [1 ]
Tsutsumi, Koichiro [1 ]
Fujii, Masakuni [1 ]
Kato, Hironari [1 ]
Hirao, Ken [1 ]
Kurihara, Naoko [1 ]
Ishida, Etsuji [1 ]
Ogawa, Tsuneyoshi [1 ]
Okada, Hiroyuki [1 ]
Yamamoto, Kazuhide [1 ]
机构
[1] Okayama Univ, Dept Gastroenterol & Hepatol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008558, Japan
关键词
K-ras mutation; IPMN; pancreatic juice; ERP; surgical indication; pancreas; PANCREATIC-JUICE; GENE-MUTATIONS; CYSTIC NEOPLASMS; PREDICTIVE FACTORS; TUMORS; P53; ADENOCARCINOMA; MALIGNANCY; PROGRESSION; MANAGEMENT;
D O I
10.1097/MPA.0b013e3181c75d9b
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives: One or more patterns of 6 K-ras mutations are detected in cells from the pancreatic juice of patients with intraductal papillary mucinous neoplasms (IPMNs). We investigated whether these mutations are associated with malignant progression. Methods: Between January 2002 and December 2007, 53 patients with IPMN were subjected to collection of pure pancreatic juice to evaluate K-ras mutation. According to the histological and radiological findings, the IPMNs were classified into 4 groups: carcinoma group, adenoma group, high-risk group, and low-risk group. We retrospectively investigated the mutation with these groups. Results: In patients with a positive K-ras mutation, a single pattern of K-ras mutation was observed in 80% (8/10) of the carcinoma group, in 71% (5/7) of the adenoma group, in 40% (2/5) of the high-risk group, and in 38% (8/21) of the low-risk group. The rate of a single pattern of K-ras mutation decreased in a stepwise order (P = 0.017). The incidence of a single pattern of K-ras mutation was significantly higher in the patients who received surgical therapy (75%, 12/16) than in those who did not (38%, 10/26; P = 0.033). Conclusions: The present study suggests that the single-clonal convergence of K-ras mutation is associated with the malignant progression of IPMNs.
引用
收藏
页码:617 / 621
页数:5
相关论文
共 31 条
[1]   Intraductal papillary mucinous tumours of the pancreas. Clinical and therapeutic issues in 32 patients [J].
Azar, C ;
VandeStadt, J ;
Rickaert, F ;
Deviere, J ;
Delhaye, M ;
Baize, M ;
Kloppel, G ;
Gelin, M ;
Cremer, M .
GUT, 1996, 39 (03) :457-464
[2]   Distinguishing benign from malignant intraductal papillary mucinous tumors of the pancreas by imaging techniques [J].
Baba, T ;
Yamaguchi, T ;
Ishihara, T ;
Kobayashi, A ;
Oshima, T ;
Sakaue, N ;
Kato, K ;
Ebara, M ;
Saisho, H .
PANCREAS, 2004, 29 (03) :212-217
[3]   Intraductal papillary-mucinous tumors of the pancreas -: Predictive criteria of malignancy according to pathological examination of 53 cases [J].
Bernard, P ;
Scoazec, JY ;
Joubert, M ;
Kahn, X ;
Le Borgne, J ;
Berger, F ;
Partensky, C .
ARCHIVES OF SURGERY, 2002, 137 (11) :1274-1278
[4]  
Fujii H, 1997, AM J PATHOL, V151, P1447
[5]   FREQUENT K-RAS MUTATIONS AND ABSENCE OF P53 MUTATIONS IN MUCIN-PRODUCING TUMORS OF THE PANCREAS [J].
HOSHI, T ;
IMAI, M ;
OGAWA, K .
JOURNAL OF SURGICAL ONCOLOGY, 1994, 55 (02) :84-91
[6]   Sequential accumulation of K-ras mutations and p53 overexpression in the progression of pancreatic mucinous cystic neoplasms to malignancy [J].
Jimenez, RE ;
Warshaw, AL ;
Z'graggen, K ;
Hartwig, W ;
Taylor, DZ ;
Compton, CC ;
Castillo, CFD .
ANNALS OF SURGERY, 1999, 230 (04) :501-509
[7]   Comparison of K-ras point mutation distributions in intraductal papillary-mucinous tumors and ductal adenocarcinoma of the pancreas [J].
Kitago, M ;
Ueda, M ;
Aiura, K ;
Suzuki, K ;
Hoshimoto, S ;
Takahashi, S ;
Mukai, M ;
Kitajima, M .
INTERNATIONAL JOURNAL OF CANCER, 2004, 110 (02) :177-182
[8]  
Kondo H, 1997, CANCER, V79, P900, DOI 10.1002/(SICI)1097-0142(19970301)79:5<900::AID-CNCR5>3.0.CO
[9]  
2-F
[10]  
Longnecker D.S., 2000, WHO Classification of Tumors of the Digestive Tract, P237